Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12625000061437Phase 4Completed
Phase 4, randomised, double-blind trial in None comparing Dexmedetomidine + propofol with Dexmedetomidine + thiopental (2 arms). Primary endpoint: LMA placement conditions. Started Oct 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12625000061437.